receptor tyrosine kinase - Globe Thesis

Keyword [receptor tyrosine kinase] Result: 81 - 100 \| Page: 5 of 10
81.	Individualized Therapy Of Advanced Non-small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
82.	Expression Of Receptor Tyrosine Kinase Axl And Its Ligand Gas6in Type Ⅰ And Ⅱ Epithelial Ovarian Carcinoma And Its Clinical Significance
83.	Inhibitors Of Non-receptor Tyrosine Kinase C-Abl Induce Mitochondria Damage And Suppress Mitophagy
84.	Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
85.	The Detection Of Different Antibodies Of Myasthenia Gravis And Its Clinical Significances
86.	Caveolin-1 Decreases The Sensibility To TKIs In Non-small Cell Lung Cancer Harboring EGFR Mutations
87.	Clinical Observation Of Targeted Drugs As A Therapy On Advanced Non-small Cell Lung Cancer
88.	Erlotinib Enhanced The CIK Cell-mediated Lysis To Lung Adenocarcinoma HCC827 Cells
89.	Efficiency And Safety Of Sequential Treatment Of Icotinib With Chemotherapy In Patients Undergoing Resection Of EGFR Mutation-positive Non-small Cell Lung Cancer
90.	The Expression And Significance Of Receptor Tyrosine Kinase Axl And Its Ligand Gas6 In Thyroid Papillary Carcinoma
91.	Expression Of Receptor Tyrosine Kinase EphA1 And PTK7 In Ovarian Serous Tumors
92.	Study On The Structure Activity Relationship Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
93.	Role Of Non-receptor Tyrosine Kinase TEC In The Production Of Pro-inflammatory Cytokines In RAW264.7 Macrophage Induced By Lipopolisaccharide
94.	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In The Treatment Of Central Nerve System Metastases From Non-Small Cell Lung Cancer
95.	The Function Of FBW7 In The Development Of Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer
96.	The Relationship With Different Status Of Epidermal Growth Factor Receptor Gene, Clinicopathological Characteristics,prognosis And Therapeutic Effect Of Patients With Non-small Cell Lung Cancer In Qinghai
97.	The Clinical Observation Of Therapeutic Regimens For Slow Progression Advanced NSCLC After First-line EGFR-TKI Therapy
98.	Study Of The Sensitivity To EGFR-TKI Modulated By P53 On Triple-negative Breast Cancer Cells
99.	The Efficacy Comparison Of Icotinib And Gefitinib In Stage Ⅳ Lung Adenocarcinoma Patients With EGFR Sensitive Gene Mutation
100.	Clinical Study Of Modified Xiaoji Decoction Combines With Cytokine Induced Killer Cells And Erlotinib In The Treating Of Advanced Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to